A story in the Jan. 25, 2005, issue of BioWorld Today should have said GTC Biotherapeutics Inc. raised $10.4 million through a sale of 7.7 million common shares at $1.35 apiece.
Editor's Note: The correction has been made in BioWorld Online.
To read more on related topics, click on one of the words below.